StonvexLoading…
StonvexStonvexStonvexCore line items from AMLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $87.37M | $380.79M | $22.23M |
Operating Income | $-153.29M | $-314.73M | $38.80M | $-201.34M |
Net Income | $-144.74M | $-301.74M | $49.27M | $-198.38M |
EPS (Diluted) | $-1.53 | $-4.43 | $0.70 | $-3.39 |
Total Assets | $332.64M | $193.63M | $517.45M | $391.45M |
Total Liabilities | $27.39M | $28.87M | $84.02M | $50.85M |
Cash & Equivalents | $226.65M | $77.39M | $170.20M | $62.53M |
Free Cash Flow OCF − CapEx | $-123.48M | $-167.80M | $10.68M | $-182.40M |
Shares Outstanding | 109.88M | 68.63M | 67.71M | 66.51M |